STOCK TITAN

inTEST Corporation Renews Stock Repurchase Plan

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
buybacks

inTEST (NYSE American: INTT) has announced the renewal of its $10 million stock repurchase plan, with approximately $9 million remaining. Since the plan's inception, the company has repurchased 141,117 shares for $1,038,850, leaving a balance of $8,961,150 available for additional repurchases.

The plan, originally authorized for stock repurchases through open market purchases from November 17, 2023 to November 17, 2024, allows the company to buy shares through open market purchases, private transactions, or under a Rule 10b5-1 plan. The timing and amount of repurchases will be determined based on market conditions and other factors.

As of October 31, 2024, inTEST had approximately 12.4 million shares outstanding. The company maintains flexibility with no fixed expiration date, and the Board can suspend or discontinue the plan without prior notice.

inTEST (NYSE American: INTT) ha annunciato il rinnovo del suo piano di riacquisto di azioni da 10 milioni di dollari, con circa 9 milioni di dollari rimanenti. Dall'inizio del piano, l'azienda ha riacquistato 141.117 azioni per 1.038.850 dollari, lasciando un saldo di 8.961.150 dollari disponibile per ulteriori riacquisti.

Il piano, originariamente autorizzato per riacquisti di azioni attraverso acquisti sul mercato aperto dal 17 novembre 2023 al 17 novembre 2024, consente all'azienda di acquistare azioni tramite acquisti sul mercato aperto, transazioni private o secondo un piano Rule 10b5-1. Il momento e l'importo dei riacquisti saranno determinati in base alle condizioni di mercato e ad altri fattori.

Al 31 ottobre 2024, inTEST aveva circa 12,4 milioni di azioni in circolazione. L'azienda mantiene flessibilità senza una data di scadenza fissa, e il Consiglio può sospendere o interrompere il piano senza preavviso.

inTEST (NYSE American: INTT) ha anunciado la renovación de su plan de recompra de acciones de 10 millones de dólares, con aproximadamente 9 millones de dólares restantes. Desde el inicio del plan, la empresa ha recomprado 141,117 acciones por 1,038,850 dólares, dejando un saldo de 8,961,150 dólares disponible para recompra adicional.

El plan, autorizado originalmente para recompras de acciones a través de compras en el mercado abierto desde el 17 de noviembre de 2023 hasta el 17 de noviembre de 2024, permite a la empresa comprar acciones a través de compras en el mercado abierto, transacciones privadas o bajo un plan de la Regla 10b5-1. El momento y la cantidad de las recompras se determinarán en función de las condiciones del mercado y otros factores.

Al 31 de octubre de 2024, inTEST tenía aproximadamente 12.4 millones de acciones en circulación. La empresa mantiene flexibilidad sin una fecha de vencimiento fija, y la Junta puede suspender o interrumpir el plan sin previo aviso.

inTEST (NYSE American: INTT)는 1천만 달러 규모의 자사주 매입 계획을 갱신했다고 발표했으며, 약 900만 달러가 남아 있습니다. 계획이 시작된 이후, 회사는 141,117주를 1,038,850달러에 재매입했으며, 추가 매입을 위해 8,961,150달러가 남아 있습니다.

이 계획은 2023년 11월 17일부터 2024년 11월 17일까지 공개 시장에서의 매입을 통해 자사주 매입을 위해 원래 승인되었으며, 회사는 공개 시장 매입, 사적 거래 또는 Rule 10b5-1 계획에 따라 주식을 매입할 수 있습니다. 매입의 시기와 금액은 시장 상황 및 기타 요인에 따라 결정됩니다.

2024년 10월 31일 기준으로 inTEST는 약 1,240만 주의 주식을 발행했습니다. 회사는 고정 만기일 없이 유연성을 유지하며, 이사회는 사전 통보 없이 계획을 중단하거나 종료할 수 있습니다.

inTEST (NYSE American: INTT) a annoncé le renouvellement de son plan de rachat d'actions de 10 millions de dollars, avec environ 9 millions de dollars restants. Depuis le début du plan, l'entreprise a racheté 141 117 actions pour 1 038 850 dollars, laissant un solde de 8 961 150 dollars disponible pour des rachats supplémentaires.

Le plan, initialement autorisé pour des rachats d'actions par le biais d'achats sur le marché ouvert du 17 novembre 2023 au 17 novembre 2024, permet à l'entreprise d'acheter des actions par le biais d'achats sur le marché ouvert, de transactions privées ou dans le cadre d'un plan de la règle 10b5-1. Le moment et le montant des rachats seront déterminés en fonction des conditions du marché et d'autres facteurs.

Au 31 octobre 2024, inTEST comptait environ 12,4 millions d'actions en circulation. L'entreprise conserve une flexibilité sans date d'expiration fixe, et le Conseil peut suspendre ou interrompre le plan sans préavis.

inTEST (NYSE American: INTT) hat die Verlängerung seines Aktienrückkaufplans in Höhe von 10 Millionen US-Dollar bekannt gegeben, von denen noch etwa 9 Millionen US-Dollar verbleiben. Seit Beginn des Plans hat das Unternehmen 141.117 Aktien für 1.038.850 US-Dollar zurückgekauft, wodurch ein Restbetrag von 8.961.150 US-Dollar für weitere Rückkäufe zur Verfügung steht.

Der ursprünglich genehmigte Plan für Aktienrückkäufe durch Käufe am offenen Markt gilt vom 17. November 2023 bis zum 17. November 2024 und ermöglicht es dem Unternehmen, Aktien durch Käufe am offenen Markt, private Transaktionen oder im Rahmen eines Regel 10b5-1 Plans zu erwerben. Der Zeitpunkt und die Höhe der Rückkäufe werden basierend auf den Marktbedingungen und anderen Faktoren bestimmt.

Am 31. Oktober 2024 hatte inTEST etwa 12,4 Millionen ausstehende Aktien. Das Unternehmen behält sich Flexibilität ohne festgelegtes Ablaufdatum vor, und der Vorstand kann den Plan ohne vorherige Ankündigung aussetzen oder einstellen.

Positive
  • Significant buyback capacity with $9M remaining
  • Demonstrates management's confidence in company's growth prospects
  • Flexible repurchase program with no fixed expiration date
  • Effective capital management mechanism
Negative
  • Only 10.4% of authorized buyback executed so far ($1.04M of $10M)
  • No commitment to complete the full repurchase program

Insights

inTEST's renewal of its $10 million stock repurchase program represents a significant capital allocation decision for a company of its size. With approximately $9 million still available (having used just over $1 million to repurchase 141,117 shares previously), the potential repurchase capacity represents roughly 9.2% of inTEST's current $97.3 million market capitalization.

For shareholders, this renewal sends a positive signal about management's confidence in the company's intrinsic value and future prospects. Stock buybacks typically benefit investors through reduced share count, potentially higher earnings per share, and support for share price through increased demand. With only about 12.4 million shares outstanding, continued execution of this program could meaningfully impact the company's capital structure.

However, several factors temper my enthusiasm: inTEST has utilized just 10.4% of the original authorization over the past period, the company explicitly states it's not obligated to complete the program, and the Board can suspend it without notice. This suggests a cautious implementation approach rather than aggressive share repurchasing.

While management's confidence is encouraging, investors should view this more as a flexible capital management tool than a firm commitment to return capital at current levels. The value creation will ultimately depend on execution timing and the prices at which shares are repurchased.

MT. LAUREL, N.J.--(BUSINESS WIRE)-- inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include semiconductor (“semi”), industrial, automotive/EV, life sciences, defense/aerospace and security, today announced that its Board of Directors has renewed its $10 million stock repurchase plan (“the plan”) which has approximately $9 million remaining.

Nick Grant, President and CEO of inTEST Corporation, “Renewing our stock repurchase plan is a confirmation of our belief in the long-term value we are creating through innovative solutions that solve our customers’ most challenging problems. It is also a statement of our confidence in our expectations to continue to grow inTEST over time as we deepen our reach into targeted markets, broaden our customer base and expand our geographic presence.”

The Company’s board originally authorized the repurchase of its common stock through open market purchases commencing November 17, 2023 and continuing through November 17, 2024, provided that the aggregate repurchases do not exceed $10.0 million. From inception through the plan’s initial expiration date, the Company had repurchased 141,117 shares for $1,038,850. The balance of the plan, or $8,961,150, is available for additional repurchases.

The stock repurchase plan is intended to provide the Company with an effective mechanism for capital management. The timing and amount of any shares repurchased under the plan will be determined by the Company, based on its evaluation of market conditions and other factors. The Company may repurchase shares from time to time on the open market, in privately negotiated transactions, or under a Rule 10b5-1 plan.

The Company is not obligated to purchase any common stock under the repurchase plan. Further, the repurchase plan has no fixed expiration date and the Board of Directors may suspend or discontinue the repurchase plan at any time without prior notice. inTEST Corporation had approximately 12.4 million shares of common stock outstanding as of October 31, 2024.

About inTEST Corporation

inTEST Corporation is a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets including automotive/EV, defense/aerospace, industrial, life sciences, and security, as well as both the front-end and back-end of the semiconductor manufacturing industry. Backed by decades of engineering expertise and a culture of operational excellence, inTEST solves difficult thermal, mechanical, and electronic challenges for customers worldwide while generating strong cash flow and profits. inTEST’s strategy leverages these strengths to grow organically and with acquisitions through the addition of innovative technologies, deeper and broader geographic reach, and market expansion. For more information, visit intest.com.

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements do not convey historical information but relate to predicted or potential future events and financial results, such as statements of the Company’s plans, strategies and intentions, or our future performance or goals, that are based upon management's current expectations, including statements related to future repurchases of the Company’s securities. These forward-looking statements can often be identified by the use of forward-looking terminology such as “believe,” “expand,” “will,” “plan,” “strategy,” or similar terminology. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Such risks and uncertainties include, but are not limited to, any mentioned in this press release as well as the Company’s ability to execute on its 5-Point Strategy, grow the Company’s presence in its key target and international markets, manage supply chain challenges, the success of the Company’s strategy to diversify its markets; changes in business conditions and general economic conditions both domestically and globally including rising interest rates and fluctuation in foreign currency exchange rates; and other risk factors set forth from time to time in the Company’s Securities and Exchange Commission filings, including, but not limited to, the Annual Report on Form 10-K for the year ended December 31, 2023. Any forward-looking statement made by the Company in this press release is based only on information currently available to management and speaks to circumstances only as of the date on which it is made. The Company undertakes no obligation to update the information in this press release to reflect events or circumstances after the date hereof or to reflect the occurrence of anticipated or unanticipated events, except as required by law.

Investors:

Deborah K. Pawlowski, IRC

Alliance Advisors IR

dpawlowski@allianceadvisors.com

Tel: (716) 843-3908

Source: inTEST Corporation

FAQ

How much money remains in inTEST's (INTT) stock repurchase plan?

Approximately $9 million remains in INTT's stock repurchase plan out of the total $10 million authorization.

How many shares has INTT repurchased under the current buyback program?

INTT has repurchased 141,117 shares for $1,038,850 since the plan's inception.

What is the timeframe for INTT's stock repurchase program?

The program was originally authorized from November 17, 2023 through November 17, 2024, with no fixed expiration date.

How many shares of INTT stock were outstanding as of October 31, 2024?

inTEST had approximately 12.4 million shares of common stock outstanding.

What methods can INTT use to repurchase shares under the program?

INTT can repurchase shares through open market purchases, privately negotiated transactions, or under a Rule 10b5-1 plan.

Intest

NYSE:INTT

INTT Rankings

INTT Latest News

INTT Stock Data

100.48M
11.07M
9.47%
59.48%
0.7%
Semiconductor Equipment & Materials
Instruments for Meas & Testing of Electricity & Elec Signals
Link
United States
MT. LAUREL